Aptevo Therapeutics (APVO) Other financing activities (2016 - 2018)
Historic Other financing activities for Aptevo Therapeutics (APVO) over the last 3 years, with Q3 2018 value amounting to $601000.0.
- Aptevo Therapeutics' Other financing activities rose 19119.88% to $601000.0 in Q3 2018 from the same period last year, while for Sep 2018 it was -$10.2 million, marking a year-over-year decrease of 50621.02%. This contributed to the annual value of -$10.0 million for FY2017, which is 60968.4% down from last year.
- According to the latest figures from Q3 2018, Aptevo Therapeutics' Other financing activities is $601000.0, which was up 19119.88% from -$10.2 million recorded in Q4 2017.
- In the past 5 years, Aptevo Therapeutics' Other financing activities registered a high of $2.4 million during Q4 2016, and its lowest value of -$10.2 million during Q4 2017.
- In the last 3 years, Aptevo Therapeutics' Other financing activities had a median value of $302500.0 in 2017 and averaged -$1.2 million.
- Its Other financing activities has fluctuated over the past 5 years, first crashed by 52972.06% in 2017, then soared by 19119.88% in 2018.
- Quarter analysis of 3 years shows Aptevo Therapeutics' Other financing activities stood at $2.4 million in 2016, then tumbled by 529.72% to -$10.2 million in 2017, then skyrocketed by 105.92% to $601000.0 in 2018.
- Its last three reported values are $601000.0 in Q3 2018, -$10.2 million for Q4 2017, and -$659000.0 during Q3 2017.